Nutrivert Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Series A2
- Latest Deal Amount
-
$2.37M
- Investors
-
8
Nutrivert General Information
Description
Operator of a biotechnology company intended to provide an alternative to livestock antibiotics. The company's postbiotics is a formulation of a feed additive that increases livestock feed conversion efficiency and selectively kills the bacteria that are susceptible to antibiotics, enabling customers to get improved output from their livestock and to control bacterial diseases in them.
Contact Information
Website
www.nutrivertglobal.comCorporate Office
- 2525 Peachtree Road NorthEast
- Suite 27
- Atlanta, GA 30305
- United States
Corporate Office
- 2525 Peachtree Road NorthEast
- Suite 27
- Atlanta, GA 30305
- United States
Nutrivert Timeline
Nutrivert Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC (Series A2) | 29-Apr-2026 | $2.37M | Completed | Clinical Trials - General | ||
| 7. Later Stage VC (Series A) | 06-Mar-2023 | Completed | Startup | |||
| 6. Accelerator/Incubator | 03-Feb-2021 | Completed | Startup | |||
| 5. Grant | 01-Oct-2020 | Completed | Startup | |||
| 4. Accelerator/Incubator | 14-Feb-2020 | Completed | Startup | |||
| 3. Accelerator/Incubator | 07-Mar-2018 | Completed | Startup | |||
| 2. Grant | 01-May-2017 | $23.8K | Completed | Startup | ||
| 1. Grant | 01-Jan-2017 | $39K | Completed | Startup |
Nutrivert Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-2 | ||||||||
| Series A-1 | ||||||||
| Series A | 250,100 | $0.001000 | $6 | $6 | 1x | $6 | 9.23% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Nutrivert Patents
Nutrivert Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025006896-A1 | Low dose muramyl dipeptide analogue-containing compositions and methods of using same for immunoprotection | Inactive | 29-Jun-2023 | ||
| AU-2021241625-A1 | Lipophilic enantiomers of desacetylglucosamine muramyl dipeptide with anti-inflammatory and growth promoting activity | Active | 26-Mar-2020 | ||
| AU-2021241625-B2 | Lipophilic enantiomers of desacetylglucosamine muramyl dipeptide with anti-inflammatory and growth promoting activity | Active | 26-Mar-2020 | ||
| CA-3172936-A1 | Lipophilic enantiomers of desacetylglucosamine muramyl dipeptide with anti-inflammatory and growth promoting activity | Pending | 26-Mar-2020 | ||
| EP-4126040-A1 | Lipophilic enantiomers of desacetylglucosamine muramyl dipeptide with anti-inflammatory and growth promoting activity | Active | 26-Mar-2020 | C07K5/06026 |
Nutrivert Signals
Nutrivert Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cultiv8 Funds Management | Venture Capital | Minority | ||
| Plug and Play | Accelerator/Incubator | Minority | ||
| Cade Museum | Other | |||
| SparkLabs Group | Venture Capital | Minority | ||
| Cultivation Capital | Venture Capital | Minority |
Nutrivert FAQs
-
When was Nutrivert founded?
Nutrivert was founded in 2016.
-
Where is Nutrivert headquartered?
Nutrivert is headquartered in Atlanta, GA.
-
What is the size of Nutrivert?
Nutrivert has 3 total employees.
-
What industry is Nutrivert in?
Nutrivert’s primary industry is Drug Discovery.
-
Is Nutrivert a private or public company?
Nutrivert is a Private company.
-
What is the current valuation of Nutrivert?
The current valuation of Nutrivert is .
-
What is Nutrivert’s current revenue?
The current revenue for Nutrivert is .
-
How much funding has Nutrivert raised over time?
Nutrivert has raised $3.98M.
-
Who are Nutrivert’s investors?
Cultiv8 Funds Management, Plug and Play, Cade Museum, SparkLabs Group, and Cultivation Capital are 5 of 8 investors who have invested in Nutrivert.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process